PROSTATE PROFITS: Report analyses drug makers who make cancer treatments

Feeds:: Posts; Comments

PROSTATE PROFITS: Report analyses drug makers who make cancer treatments

May 19, 2009 by Jim Tucker

MAY 19: PROSTABLOG NZ: Someone’s making a lot of money from prostate cancer sufferers, as a report analysing world-wide markets for prostate cancer therapeutics (mostly hormonal therapies) – including 138 companies - shows. READ MORE>

Posted in New prostate drugs, PROSTATE CANCER, Prostate drugs, Treatment debate | Tagged prostate, PROSTATE CANCER, prostate cancer treatments, prostablog, prostate blog, World Prostate Cancer Therapeutics Market, hormonal therapies, prostate drug market, prostate drug makers, Reportlinker, Abbott Laboratories, AEterna Zentaris Inc., ALZA Corporation, Amgen Inc., AstraZeneca PLC., Medimmune, LLC, Bristol-Myers Squibb Company, Cell Genesys Inc., Dendreon Corporation, EUSA Pharma, (USA) Inc., F. Hoffmann-La Roche Ltd., Genentech Inc., GlaxoSmithKline Plc., Immunomedics, Inc., Indevus Pharmaceuticals Inc., Novartis AG, OSI Pharmaceuticals, Paladin Labs Inc., Pfizer Inc., Progenics Pharmaceuticals, Sanofi-Aventis SA, Spectrum Pharmaceuticals, Takeda Pharmaceutical Company Limited | No Comments Yet

Comments RSS

	Ants Parder on NZ Guidelines Group 2009 cance…
	Mike Demarco on NZ Guidelines Group 2009 cance…
	Leslie Mutchler on READER’S DIGEST screenin…
	juan perez on PROSTATE BIOPSY: Study looks a…
	Sandy on Gleason score 6 for prostate c…

Prostablog

By Jim Tucker

PROSTATE PROFITS: Report analyses drug makers who make cancer treatments

Leave a Reply

MY PROSTATE STORY

Prostate Cancer Foundation of NZ

Prostate inquiry

Prostate websites

PROSTABLOG pages

Stories posted so far

StatCounter

Prostablog RSS – click here

COMMENTS

TOPICS

Jim's Flickr photos